SMTPs are a family of small-molecule plasminogen modulators that enhance plasminogen activation. SMTP-7, one of the most potent congeners, is effective in treating thrombotic cerebral infarction. The SMTP molecule consists of a tricyclic c-lactam moiety, a geranylmethyl group, and an N-linked side chain. The presence of both an aromatic group and a negatively ionizable group in the N-linked side chain is crucial for activity. Investigations of the congeners with a phenylglycine-based side chain suggest that a phenolic hydroxy group affects potency. In this study, we isolate and characterize a series of novel SMTP congeners with a phenylamine-based N-linked side chain. Of the 11 congeners isolated, SMTP-19 (with a 4-phenylcarboxylic acid moiety), SMTP-22 (with a 3-hydroxyphenyl-4-carboxylic acid moiety) and SMTP-25 (with a 2-hydroxyphenyl-3-carboxylic acid moiety) are as potent as SMTP-7 in plasminogen-modulating activity. Their isomers with a carboxylic acid group and/or a phenolic hydroxy group at different positions have o40% of the activity of these congeners. Both SMTP-22 and SMTP-25 have 41.7 times more oxygen radical absorbance capacity as compared with SMTP-7.
INTRODUCTION
The plasminogen/plasmin system has a crucial role in blood clot lysis and other pathophysiological events involving localized extracellular proteolysis. 1,2 Plasminogen is a zymogen that is proteolytically activated, via cleavage at Arg 561 -Val 562 , to plasmin by tissue-type and urokinase-type plasminogen activators (t-PA and u-PA, respectively). 1 Plasminogen adopts tight conformation because of intramolecular binding of Lys 50 and/or Lys 62 to the lysine-binding site in the fifth kringle domain, 3,4 rendering the plasminogen molecule less sensitive to activation by plasminogen activators. Upon binding to fibrin and cellular receptors, plasminogen adopts relaxed conformation and is efficiently activated on these substrata, leading to extracellular proteolysis. 5 SMTPs, a family of triprenyl phenol metabolites produced by Stachybotrys microspora, enhance plasminogen activation by modulating plasminogen conformation. [5] [6] [7] SMTP-7, one of the most potent congeners, is effective in treating thrombotic stroke in animal models, [8] [9] [10] [11] possibly involving a neuroprotective mechanism. [10] [11] [12] The SMTP molecule consists of a tricyclic g-lactam moiety, a geranylmethyl group, and an N-linked side chain. Previous studies have identified 31 SMTP congeners, most of which differ in the N-linked side chain. [13] [14] [15] [16] [17] [18] [19] [20] The N-linked side chain structure of SMTP affects the plasminogen-modulating activity of the congeners. It has been suggested that a negatively ionizable group in the side chain is crucial for activity. 19 Among congeners with a negatively ionizable side chain, one with an aromatic group is more active than that with an aliphatic group. 19 Investigations of the congeners with a phenylglycine-based side chain suggest that a phenolic hydroxy group in the side chain affects potency of a congener. 20 In this study, we isolated 11 new SMTP congeners with a phenylamine-based side chain and investigated the roles for a side chain-phenolic hydroxy group and a carboxylic acid group in the plasminogen-modulating activity. This paper deals with the isolation and characterization of these congeners. Part of the results has been disclosed as a patent. 21 Biological activities of some of the new congeners have also been described in the patent literatures. [22] [23] [24] RESULTS AND DISCUSSION Production, isolation, and physico-chemical properties The 11 new SMTP congeners were produced by S. microspora fed with various phenylamines (Table 1) . In this precursor amine-fed culture method, the fed amines were incorporated as the N-linked side chain of the SMTP molecule. 18, 25 The products were isolated by reversedphase HPLC. The yields of the 11 congeners varied from 95 to 993 mg l À1 (Table 1) .
Physico-chemical properties of the new congeners are summarized in Table 2 . NMR signals (Supplementary Figures S1-S11) are assigned as shown in Table 3 , according to the results from 1 H-1 H-correlation, hetero-nuclear multiple quantum coherence and hetero-nuclear multiple-bond connectivity spectroscopies. Based on these results obtained, we propose the structures of the new congeners as shown in Figure 1a . The conclusion is consistent with the idea that the fed amine is introduced as the N-linked side chain of an SMTP molecule. 17, 18, 25 Plasminogen-modulating activity Plasminogen-modulating activities of the 11 new SMTP congeners ( Figure 1b) were assessed as the activity to enhance plasminogen activation catalyzed by u-PA. SMTP-18, which had a 4-phenol moiety as the N-linked side chain, was weak in activity, giving 10-fold enhancement (EC 10 ) at 182 mM and maximum enhancement (E max ) of 18-fold. The ratio E max /EC 10 was 0.10-fold mM
À1
, which was B1/16 of that of SMTP-7 (1.57-fold mM
), one of the most potent congener to be identified (Figure 1c ). SMTP-19, an analog with 29-COOH, gave EC 10 at 86 mM and E max of 126-fold, resulting in E max /EC 10 of 1.47-fold mM
, which was comparable to that of SMTP-7. The isomers SMTP-20 (with 28-COOH) and SMTP-21 (with 27-COOH) were much less active than SMTP-19 (E max /EC 10 ). Two other 28-COOH isomers, SMTP-26 (with 28-COOH and 29-OH) and SMTP-27 (with 28-COOH and 31-OH), were much less active than SMTP-25.
Thus, among the series of SMTP congeners with a phenylaminebased side chain, SMTP-19 (with 29-COOH), SMTP-22 (with 28-OH and 29-COOH) and SMTP-25 (with 27-OH and 28-COOH) are potent in enhancing plasminogen activation catalyzed by u-PA. The activity of each of these compounds is comparable to that of SMTP-7, which has two-triprenyl-phenol units with a MW of 868. The new potent congeners have a single triprenyl phenol unit, and their MWs are 506. 25-522.25 . A phenolic hydroxy group reduces the activity of a congener with a phenylglycine-based side chain, 20 but has differential effects in activity in combination with a carboxylic acid group. For example, with respect to the congeners with 28-COOH, the presence of 27-OH (SMTP-25) greatly increases activity compared with the congener with 28-COOH but without a hydroxy group . The isomers with 29-OH (SMTP-26) or 31-OH (SMTP-27) are much less active than SMTP-25.
Antioxidant activity
The core structure of SMTP resembles tocopherols, which have significant antioxidant activities. Both in vivo and in vitro studies suggest that part of the SMTP-7 activity in the amelioration of ischemic stroke can be attributable to its antioxidant property. [10] [11] [12] Hence, we evaluated antioxidant activities of the new SMTP congeners utilizing the oxygen radical absorbance capacity (ORAC) method, which measured peroxy radical scavenging activity ( Figure 1c ). SMTP-7 had approximately two times as high ORAC value as the water-soluble tocopherol analog trolox (2.08 TE (trolox equivalent)). SMTP-19, -20 and -21 had ORAC values of 1.36-3.57 TE. Except for SMTP-26, the congeners with a phenolic hydroxy group in addition to a carboxylic acid group at any positions had higher ORAC values (3.63-6.89 TE) compared with the congeners with a carboxylic acid group alone. Thus, the N-linked side chain structure of the SMTP molecule affects antioxidant activity, and the structural requirement for antioxidant activity seems unrelated to that for plasminogen modulator activity. Both SMTP-22 and SMTP-25 have higher plasminogen-modulating and antioxidant activities.
EXPERIMENTAL PROCEDURE Materials
Human native plasminogen (Glu 1 -plasminogen) was isolated on lysineSepharose affinity chromatography. H-Val-Leu-Lys-p-nitroanilide (VLKpNA), a chromogenic substrate for plasmin, was obtained from Bachem (Bubendorf, Switzerland). Two-chain u-PA (tcu-PA) was purchased from JCR Pharmaceuticals (Kobe, Japan). SMTP-7 was prepared as described previously. 16 SMTP congeners were converted to sodium salt before assay of plasminogen activation and antioxidant activity.
Production and isolation of new SMTP congeners
S. microspora IFO 30018 was incubated at 25 1C for 4 days in a 500-ml Erlenmeyer flask containing 100 ml of a seed medium consisting of glucose (4%), soybean meal (0.5%), peptone (0.3%), yeast extract (0.3%) and the antifoam CB442 (Nippon Oil & Fat Co, Tokyo, Japan.) (0.01%), pH 5.8. Aliquot of the seed culture (5 ml) was transferred to a 500-ml Erlenmeyer flask containing 100 ml of a production medium consisting of sucrose (5%), yeast extract (0.1%), KNO 3 (0.7%), K 2 HPO 4 (1.5%), MgSO 4 7 H 2 O (0.05%), KCl (0.05%), CoCl 2 6 H 2 O (0.00025%), FeSO 4 7 H 2 O (0.0015%), CaCl 2 2 H 2 O (0.00065%) and CB442 (0.01%), pH 5.8. Flasks were incubated at 25 1C on a rotary shaker at 180 r.p.m. After 96 h, 100 mg of organic amine (see Table 1 ) was added, and the flask was incubated further for 40 h.
The culture was mixed with 200 ml of MeOH, and the mixture was filtered and concentrated to remove MeOH. After adjusting pH to 2 with phosphoric acid, the concentrate was settled overnight at 4 1C. Precipitates formed were collected by centrifugation and dissolved in acetone. After evaporation, resulting oily residue was dissolved in MeOH, treated with Lichrolut RP-18 (Merck KGaA, Darmstadt, Germany), and subjected to preparative HPLC on an Inertsil PREP-ODS (30 Â 250 mm; GL Science, Tokyo, Japan). The column was developed at a rate of 25 ml min À1 at 40 1C with a solvent mixture shown in Table 1 . Fractions containing desired compound were evaporated to remove MeOH. Purified materials were obtained after ethyl acetate extraction (with ammonium acetate-containing solvent) or direct evaporation (with MeOH solvent). The yield of each congener is shown in Table 1 .
Assay for plasminogen activation
The activation of plasminogen was assayed by measuring initial velocity for tcu-PA-catalyzed plasmin generation using the chromogenic substrate New No. No. New SMTPs with a phenylamine-based side chain H Koide et al New SMTPs with a phenylamine-based side chain H Koide et al
